ACADVL (Gene)

Synonyms:ACAD6, ACADVL, ENTREZ:37, HGNC:92, LCACD, MIM:609575, NM_000018, NM_001033859, NM_001270447, NM_001270448, NP_000009, NP_001029031, NP_001257376, NP_001257377, VLCAD, XM_006721516, XM_011523829, XM_011523830, XM_024450741, XP_006721579, XP_011522131, XP_011522132, XP_024306509, XR_934021, XR_934022, XR_934023, acyl-CoA dehydrogenase very long chain
Omim:OMIM:609575
Id:ENSG00000072778
Hgnc:HGNC:92
Entrez:37
Description:acyl-CoA dehydrogenase very long chain
The protein encoded by this gene is targeted to the inner mitochondrial membrane where it catalyzes the first step of the mitochondrial fatty acid beta-oxidation pathway. This acyl-Coenzyme A dehydrogenase is specific to long-chain and very-long-chain fatty acids. A deficiency in this gene product reduces myocardial fatty acid beta-oxidation and is associated with cardiomyopathy. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View ACADVL's neighborhood in the knowledge graph.

Playbook Workflow Builder
Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with ACADVL.

Gene Partnership Appyter
CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using ACADVL.

Gene and Drug Landing Page Aggregator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for ACADVL.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with ACADVL.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.